Wegovy® for Medical Weight Loss in Hackensack, NJ

Wegovy® is a prescription medication that contains semaglutide, a GLP-1 receptor agonist. Originally developed for the treatment of type 2 diabetes, Wegovy® has been approved for weight loss in individuals who are overweight or obese. At The Institute for Weight Management, we use Wegovy® as part of a comprehensive weight loss plan to help individuals achieve sustainable and long-term results.

Wegovy® aids in weight loss by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1), which regulates hunger and insulin release. When administered, Wegovy® helps control appetite by slowing down gastric emptying, making individuals feel fuller for longer periods after eating. This reduction in hunger helps prevent overeating and reduces cravings, making it easier for patients to adhere to a calorie-restricted diet. Additionally, Wegovy® works by enhancing insulin sensitivity and lowering blood sugar levels, which further contributes to weight loss, especially for those with insulin resistance.

At The Institute for Weight Management, we provide personalized guidance to ensure Wegovy® is part of a balanced weight loss plan that includes nutrition, exercise, and behavioral changes. Wegovy® helps individuals reduce body fat while preserving lean muscle mass, leading to healthier, more sustainable weight loss. The medication is an effective tool for those struggling with weight loss and helps achieve both improved physical health and long-term lifestyle changes.

Wegovy® is administered as a once-weekly injection. At The Institute for Weight Management, our team provides detailed instructions on how to administer the injection correctly. The weekly injection is designed to be convenient and easy to incorporate into your routine, with no need for daily doses. Wegovy® comes in a pre-filled pen that allows for easy self-injection, typically administered in the thigh, abdomen, or upper arm.

When starting treatment with Wegovy®, the dosage begins at a low level to help minimize potential side effects, such as nausea, and gradually increases over time. This gradual dose escalation allows your body to adjust to the medication before reaching the optimal therapeutic dose. As the dose is increased, the medication becomes more effective at controlling appetite and promoting weight loss. Patients typically begin with a lower dose in the first few weeks, and after about 4-5 weeks, the full dose is reached. This approach ensures a smoother transition and improves the likelihood of successful treatment.

Our team at The Institute for Weight Management offers continuous support, monitoring your progress and ensuring that the treatment is working as expected. If you experience any side effects or have concerns about the injections, we are here to adjust your treatment and provide guidance. Wegovy® is designed to be a long-term solution for weight management, and with regular follow-ups, we can optimize the treatment to ensure safe and effective results.

The time it takes to see results with Wegovy® for weight loss varies depending on individual factors such as metabolism, lifestyle habits, and adherence to the treatment plan. However, many patients begin to notice weight loss results within the first 4-6 weeks of starting Wegovy®. At The Institute for Weight Management, we typically recommend that patients incorporate healthy eating habits and regular exercise to maximize the benefits of Wegovy®.

Clinical studies have shown that patients using Wegovy® can expect to lose an average of 15% or more of their body weight over the course of 68 weeks when combined with lifestyle changes like diet and exercise. Some patients may notice more significant weight loss early on, while others may experience gradual progress over several months. The key is consistency in following the prescribed plan, including diet modifications, physical activity, and regular weekly injections.

It is important to note that weight loss results can vary based on individual factors, and some people may experience more rapid changes than others. At The Institute for Weight Management, we track your progress closely, making adjustments to your treatment plan if necessary to ensure optimal results. Wegovy® is a powerful tool, but sustainable weight loss relies on a comprehensive approach, including nutrition and behavioral changes. By combining Wegovy® with professional support and personalized guidance, you can achieve lasting weight loss results over time.

Wegovy® is approved for weight loss in individuals who meet specific eligibility criteria. At The Institute for Weight Management, we carefully evaluate each patient’s medical history, health status, and weight loss goals to determine if Wegovy® is a suitable treatment option. The primary criteria for eligibility include being overweight (with a BMI of 27 or higher) or obese (with a BMI of 30 or higher). In addition, Wegovy® is recommended for individuals who have weight-related health issues, such as high blood pressure, type 2 diabetes, or high cholesterol, that may benefit from weight loss.

Wegovy® is typically prescribed for adults who are unable to lose weight through diet and exercise alone and who need additional support for weight management. It may also be an option for individuals who have been unable to achieve or maintain weight loss through other methods. However, Wegovy® is not recommended for individuals who have a personal or family history of thyroid cancer, certain types of thyroid disease, or pancreatitis.

At The Institute for Weight Management, we offer a thorough consultation to assess your eligibility for Wegovy® and determine if it aligns with your health needs. Our team works closely with you to ensure that Wegovy® is incorporated into a personalized, medically supervised weight loss program. We also monitor your progress throughout the treatment to ensure that you are achieving your weight loss goals safely and effectively. If Wegovy® is not the right option for you, we explore alternative treatments and support strategies to help you achieve long-term success in your weight loss journey.

Wegovy® injections are a breakthrough treatment for medical weight loss, designed to help those facing challenges with obesity or weight-related health conditions. Under the expert supervision of Dr. Anjana Chhabra at The Institute for Weight Management, Wegovy® works by mimicking a natural hormone in the body that controls appetite. This medication helps to decrease hunger and increase feelings of fullness, allowing you to make healthier food choices and reduce calorie intake more effectively.

Wegovy® is most effective when combined with a balanced diet and regular physical activity, helping patients achieve sustainable weight loss over time. By targeting the brain’s hunger signals, Wegovy® can help curb cravings, making it easier to stick to a weight loss plan and avoid overeating.

Dr. Chhabra and her team provide personalized care, customizing a treatment plan that aligns with your weight loss goals. With regular monitoring and support at The Institute for Weight Management, Wegovy® injections can play a key role in helping you achieve and maintain a healthier weight. Contact us today or book an appointment online for personalized care that works for you. Conveniently located at 150 Overlook Ave, Hackensack, NJ 07601, we proudly serve clients from Ridgewood, Tenafly, Glen Rock, Paramus, Oradell, River Edge, Upper Saddle River, Wyckoff, and surrounding areas.